REQUEST A DEMO
Total
USD $0.00
Search more companies

M-Pharma Ruse3 (М-Фарма Русе ЕООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: M-Pharma Ruse3 Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

M-Pharma Ruse3 (М-Фарма Русе ЕООД) is a company in Bulgaria, with a head office in Ruse. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on September 13, 2026. It currently has a total number of 11 (2024) employees. From the latest financial highlights, M-Pharma Ruse3 (М-Фарма Русе ЕООД) reported a net sales revenue increase of 34.19% in 2024. During that time, M-Pharma Ruse3 (М-Фарма Русе ЕООД)’s total assets grew by 2.1%.

Headquarters
Ul. Pliska 3
Ruse; Ruse; Postal Code: 7000

Contact Details: Purchase the M-Pharma Ruse3 (М-Фарма Русе ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the M-Pharma Ruse3 (М-Фарма Русе ЕООД) report to view the information.
Registered Capital:
Purchase the M-Pharma Ruse3 (М-Фарма Русе ЕООД) report to view the information.
Financial Auditors:
Purchase the M-Pharma Ruse3 (М-Фарма Русе ЕООД) report to view the information.
Incorporation Date:
September 13, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after M-Pharma Ruse3 (М-Фарма Русе ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
34.19%
Total Operating Revenue
34.19%
Operating Profit
32.61%
EBITDA
-1.33%
Net Profit/Loss for the Period
34.21%
Total Assets
2.1%
Total Equity
20.16%
Operating Profit Margin
-0.02%
Net Profit Margin
0%
Return on Equity (ROE)
1.76%
Debt / Equity
-44.56%
Quick Ratio
0.09%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?